Literature DB >> 26907869

[Future interventional procedures for valve diseases].

T Thielsen1, C Frerker2, T Schmidt2, M Schlüter3, F Kreidel2, H Alessandrini2, K-H Kuck2.   

Abstract

BACKGROUND: Percutaneous valve therapies represent one of the most innovative areas within interventional cardiology in the past 10 years. AIM: The aim of this work is to give an overview of current and upcoming therapeutic options.
MATERIALS AND METHODS: In this manuscript, the results of a retro- and prospective literature research are summarized. RESULTS AND DISCUSSION: With the introduction of percutaneous therapies for valvular heart disease, patients who were previously considered too ill for surgery can now be treated. The percutaneous treatment of aortic or mitral valve disease has become standard therapy. Likewise, promising results have been obtained for percutaneous treatment options for pathologies of the tricuspid valve, which are still under intense investigation.

Entities:  

Keywords:  Catheter intervention; Mitral valve; Percutaneous treatment; Transcatheter aortic valve implantation; Tricuspid valve

Mesh:

Year:  2016        PMID: 26907869     DOI: 10.1007/s00108-016-0029-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  33 in total

1.  Percutaneous edge-to-edge mitral valve repair: 2-year follow-up in the first human case.

Authors:  José Antonio Condado; Harry Acquatella; Leonardo Rodriguez; Patrick Whitlow; Manuel Vélez-Gimo; Frederick G St Goar
Journal:  Catheter Cardiovasc Interv       Date:  2006-02       Impact factor: 2.692

2.  Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description.

Authors:  Alain Cribier; Helene Eltchaninoff; Assaf Bash; Nicolas Borenstein; Christophe Tron; Fabrice Bauer; Genevieve Derumeaux; Frederic Anselme; François Laborde; Martin B Leon
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

3.  5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.

Authors:  Samir R Kapadia; Martin B Leon; Raj R Makkar; E Murat Tuzcu; Lars G Svensson; Susheel Kodali; John G Webb; Michael J Mack; Pamela S Douglas; Vinod H Thourani; Vasilis C Babaliaros; Howard C Herrmann; Wilson Y Szeto; Augusto D Pichard; Mathew R Williams; Gregory P Fontana; D Craig Miller; William N Anderson; Jodi J Akin; Michael J Davidson; Craig R Smith
Journal:  Lancet       Date:  2015-03-15       Impact factor: 79.321

4.  First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve.

Authors:  Joachim Schofer; Klaudija Bijuklic; Claudia Tiburtius; Lorenz Hansen; Adam Groothuis; Rebecca T Hahn
Journal:  J Am Coll Cardiol       Date:  2015-03-04       Impact factor: 24.094

5.  Clinical application of transvenous mitral commissurotomy by a new balloon catheter.

Authors:  K Inoue; T Owaki; T Nakamura; F Kitamura; N Miyamoto
Journal:  J Thorac Cardiovasc Surg       Date:  1984-03       Impact factor: 5.209

6.  Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.

Authors:  M Lindroos; M Kupari; J Heikkilä; R Tilvis
Journal:  J Am Coll Cardiol       Date:  1993-04       Impact factor: 24.094

7.  Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Lung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala
Journal:  Eur J Cardiothorac Surg       Date:  2012-08-25       Impact factor: 4.191

8.  Transcatheter aortic valve implantation in failed bioprosthetic surgical valves.

Authors:  Danny Dvir; John G Webb; Sabine Bleiziffer; Miralem Pasic; Ron Waksman; Susheel Kodali; Marco Barbanti; Azeem Latib; Ulrich Schaefer; Josep Rodés-Cabau; Hendrik Treede; Nicolo Piazza; David Hildick-Smith; Dominique Himbert; Thomas Walther; Christian Hengstenberg; Henrik Nissen; Raffi Bekeredjian; Patrizia Presbitero; Enrico Ferrari; Amit Segev; Arend de Weger; Stephan Windecker; Neil E Moat; Massimo Napodano; Manuel Wilbring; Alfredo G Cerillo; Stephen Brecker; Didier Tchetche; Thierry Lefèvre; Federico De Marco; Claudia Fiorina; Anna Sonia Petronio; Rui C Teles; Luca Testa; Jean-Claude Laborde; Martin B Leon; Ran Kornowski
Journal:  JAMA       Date:  2014-07       Impact factor: 56.272

9.  5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction.

Authors:  Anson Cheung; John G Webb; Marco Barbanti; Melanie Freeman; Ronald K Binder; Christopher Thompson; David A Wood; Jian Ye
Journal:  J Am Coll Cardiol       Date:  2013-02-28       Impact factor: 24.094

10.  Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial.

Authors:  Tomasz Siminiak; Justina C Wu; Michael Haude; Uta C Hoppe; Jerzy Sadowski; Janusz Lipiecki; Jean Fajadet; Amil M Shah; Ted Feldman; David M Kaye; Steven L Goldberg; Wayne C Levy; Scott D Solomon; David G Reuter
Journal:  Eur J Heart Fail       Date:  2012-05-21       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.